Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017682452> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2017682452 endingPage "10" @default.
- W2017682452 startingPage "1" @default.
- W2017682452 abstract "To determine the safety, maximum tolerated dose, and preliminary efficacy of concomitant interferon-alpha and zidovudine therapy in AIDS-related Kaposi's sarcoma (KS), 56 patients with biopsy-proven KS and documented human immunodeficiency virus type 1 (HIV) infection were enrolled into a phase I study. Interferon-alpha was given intramuscularly at a dose of 9, 18, or 27 mu once a day and zidovudine was administered as 100 or 200 mg every 4 h for 8 weeks followed by a 48-week maintenance period. The major toxicities were anemia, neutropenia, and hepatotoxicity. Neutropenia was dose limiting with 1,200 mg of zidovudine/day and the lowest dose of interferon-alpha (9 mu/day). Hepatotoxicity was dose limiting with 27 mu of interferon and 600 mg of zidovudine/day. Cumulative dose-related anemia or neutropenia was not seen during long-term follow-up. The maximum tolerated doses for the combination were defined as 18 mu daily for interferon-alpha and 600 mg daily for zidovudine. Variable changes in CD4 lymphocytes occurred during the first 8 weeks of therapy. At higher doses of the combination, sustained increases in median CD4 lymphocyte numbers were noted (p less than 0.001). In HIV antigenemic patients, progressive antigen suppression was seen with increasing doses of the combination (p less than 0.005). The overall antitumor response rate was 47%. Tumor regression was associated with better survival benefits (p less than 0.001) and a pretreatment CD4 cell count greater than or equal to 200 cells/mm3 (p = 0.01). In conclusion, intermediate doses of interferon-alpha and lower doses of zidovudine appear to be relatively well tolerated and associated with disease improvement, including survival benefits." @default.
- W2017682452 created "2016-06-24" @default.
- W2017682452 creator A5000189544 @default.
- W2017682452 creator A5011161352 @default.
- W2017682452 creator A5029282622 @default.
- W2017682452 creator A5034409559 @default.
- W2017682452 creator A5041928760 @default.
- W2017682452 creator A5045564855 @default.
- W2017682452 creator A5051215829 @default.
- W2017682452 creator A5060567703 @default.
- W2017682452 creator A5081022930 @default.
- W2017682452 creator A5084232309 @default.
- W2017682452 date "1991-01-01" @default.
- W2017682452 modified "2023-10-03" @default.
- W2017682452 title "A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma." @default.
- W2017682452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1670585" @default.
- W2017682452 hasPublicationYear "1991" @default.
- W2017682452 type Work @default.
- W2017682452 sameAs 2017682452 @default.
- W2017682452 citedByCount "33" @default.
- W2017682452 countsByYear W20176824522016 @default.
- W2017682452 countsByYear W20176824522017 @default.
- W2017682452 crossrefType "journal-article" @default.
- W2017682452 hasAuthorship W2017682452A5000189544 @default.
- W2017682452 hasAuthorship W2017682452A5011161352 @default.
- W2017682452 hasAuthorship W2017682452A5029282622 @default.
- W2017682452 hasAuthorship W2017682452A5034409559 @default.
- W2017682452 hasAuthorship W2017682452A5041928760 @default.
- W2017682452 hasAuthorship W2017682452A5045564855 @default.
- W2017682452 hasAuthorship W2017682452A5051215829 @default.
- W2017682452 hasAuthorship W2017682452A5060567703 @default.
- W2017682452 hasAuthorship W2017682452A5081022930 @default.
- W2017682452 hasAuthorship W2017682452A5084232309 @default.
- W2017682452 hasConcept C113842279 @default.
- W2017682452 hasConcept C126322002 @default.
- W2017682452 hasConcept C203014093 @default.
- W2017682452 hasConcept C2522874641 @default.
- W2017682452 hasConcept C2776178377 @default.
- W2017682452 hasConcept C2776694085 @default.
- W2017682452 hasConcept C2776999253 @default.
- W2017682452 hasConcept C2777063308 @default.
- W2017682452 hasConcept C2779384505 @default.
- W2017682452 hasConcept C2780216070 @default.
- W2017682452 hasConcept C2780727368 @default.
- W2017682452 hasConcept C2781228144 @default.
- W2017682452 hasConcept C2909179924 @default.
- W2017682452 hasConcept C54355233 @default.
- W2017682452 hasConcept C71924100 @default.
- W2017682452 hasConcept C81885089 @default.
- W2017682452 hasConcept C86803240 @default.
- W2017682452 hasConcept C90924648 @default.
- W2017682452 hasConceptScore W2017682452C113842279 @default.
- W2017682452 hasConceptScore W2017682452C126322002 @default.
- W2017682452 hasConceptScore W2017682452C203014093 @default.
- W2017682452 hasConceptScore W2017682452C2522874641 @default.
- W2017682452 hasConceptScore W2017682452C2776178377 @default.
- W2017682452 hasConceptScore W2017682452C2776694085 @default.
- W2017682452 hasConceptScore W2017682452C2776999253 @default.
- W2017682452 hasConceptScore W2017682452C2777063308 @default.
- W2017682452 hasConceptScore W2017682452C2779384505 @default.
- W2017682452 hasConceptScore W2017682452C2780216070 @default.
- W2017682452 hasConceptScore W2017682452C2780727368 @default.
- W2017682452 hasConceptScore W2017682452C2781228144 @default.
- W2017682452 hasConceptScore W2017682452C2909179924 @default.
- W2017682452 hasConceptScore W2017682452C54355233 @default.
- W2017682452 hasConceptScore W2017682452C71924100 @default.
- W2017682452 hasConceptScore W2017682452C81885089 @default.
- W2017682452 hasConceptScore W2017682452C86803240 @default.
- W2017682452 hasConceptScore W2017682452C90924648 @default.
- W2017682452 hasIssue "1" @default.
- W2017682452 hasLocation W20176824521 @default.
- W2017682452 hasOpenAccess W2017682452 @default.
- W2017682452 hasPrimaryLocation W20176824521 @default.
- W2017682452 hasRelatedWork W1595172314 @default.
- W2017682452 hasRelatedWork W1976672969 @default.
- W2017682452 hasRelatedWork W2017682452 @default.
- W2017682452 hasRelatedWork W2023750948 @default.
- W2017682452 hasRelatedWork W2033952010 @default.
- W2017682452 hasRelatedWork W2074284686 @default.
- W2017682452 hasRelatedWork W2417331186 @default.
- W2017682452 hasRelatedWork W2438653439 @default.
- W2017682452 hasRelatedWork W2461318346 @default.
- W2017682452 hasRelatedWork W4290218247 @default.
- W2017682452 hasVolume "4" @default.
- W2017682452 isParatext "false" @default.
- W2017682452 isRetracted "false" @default.
- W2017682452 magId "2017682452" @default.
- W2017682452 workType "article" @default.